Navigation Links
Nektar Therapeutics Reports Second Quarter 2009 Financial Results

) (64,215) (73,820) (Benefit) provision for income taxes (206) 47 (339) 260 ---- --- ---- --- Net loss $(32,069) $(33,375) $(63,876) $(74,080) ======== ======== ======== ======== Basic and diluted net loss per share $(0.35) $(0.36) $(0.69) $(0.80) Shares used in computing basic and diluted net loss per share 92,556 92,400 92,536 92,365

                            NEKTAR THERAPEUTICS
                               (In thousands)

                ASSETS              June 30, 2009    December 31, 2008(1)
                                    -------------    -----------------
    Current assets:
      Cash and cash equivalents        $114,992           $155,584
      Short-term investments            179,311            223,410
      Accounts receivable, net
       of allowance                       8,473             11,161
      Inventory                          10,110              9,319
      Other current assets                5,317              6,746
                                          -----              -----
        Total current assets           $318,203           $406,220

    Property and equipment, net          75,024             73,578
    Goodwill                             76,501             76,501
    Other assets                          3,270              4,237
                                          -----              -----
      Total  assets                    $472,998           $560,536
                                       ========           ========


    Current liabilities:
      Accounts payable    
SOURCE Nektar Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Nektar Commences Phase 2 Clinical Development Program for NKTR-102 (PEG-Irinotecan) in Colorectal Cancer
2. Nektar Commences Phase 2 Trial of NKTR-118 (oral PEG-naloxol) Evaluating Efficacy and Safety as Treatment for Opioid-Induced Bowel Dysfunction
3. Nektar Terminates All Negotiations With Potential Partners for Inhaled Insulin; Increased Number of Lung Cancer Cases Observed in Ongoing Clinical Studies of Inhaled Insulin Patients
4. Nektar Therapeutics to Present Positive Data at Upcoming Medical and Scientific Meetings
5. Nektar to Webcast Presentation of Phase 1 Clinical Results for Lead Small Molecule PEG-Oncolytic Program, NKTR-102 (PEG-irinotecan)
6. Nektar Announces Expanded Phase 2 Clinical Development Plan For NKTR-102 (PEG-irinotecan)
7. Nektar Announces Positive Results from Phase 2 Study of Oral NKTR-118 in Patients with Opioid-Induced Constipation (OIC)
8. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
9. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
10. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
11. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
Post Your Comments:
(Date:7/23/2014)... , July 23, 2014 On Tuesday, ... ("Plaintiff") filed suit in the 116 th ... , against RegenLab USA, LLC ... Prospective Business Relationships through false and misleading ... Business Disparagement through libel, disparagement, defamation, ...
(Date:7/23/2014)... July 23, 2014 /PRNewswire-iReach/ -- The Centers for Medicare ... Quality Innovation Network-Quality Improvement Organization (QIN-QIO) contract to a ... Effective August 1, WVMI will launch Quality ... , Pennsylvania , ... and Louisiana.  The Network will engage providers and the ...
(Date:7/23/2014)... -- RT Oncology Services Corporation today announced that Craig ... directors. Mr. Mundie is currently senior advisor to the ... projects within the company and on technology strategy and ... officer. Mike Martin , president ... a visionary technology executive. His appointment is part of ...
Breaking Medicine Technology:Announcing a New Regional Approach to Medicare Quality Improvement 2Craig Mundie Joins RainTree Oncology Board of Directors 2Craig Mundie Joins RainTree Oncology Board of Directors 3
... , , WALTHAM, Mass., ... research and advisory firms for pharmaceutical and healthcare issues, finds ... cause the schizophrenia drug market to decrease from $6.3 billion ... States, France, Germany, Italy, Spain, the United Kingdom and Japan. ...
... , , BIRMINGHAM, Ala., Dec. 2 ... cancer. For adults 65 and over, the odds of losing vision are ... are one in six and odds of a woman developing breast cancer ... aging adults by increasing the risk of injuries, depression and inability to ...
Cached Medicine Technology:Generic Erosion of Established Branded Atypical Antipsychotics Will Cause the Schizophrenia Drug Market To Decline More Than $1 Billion by 2013 2Risk of Vision Loss in Aging Adults is Greater Than Risk of Breast or Prostate Cancer 2
(Date:7/23/2014)... 23, 2014 Recently, has launched ... the company is announcing a promotion of wedding dresses. ... will end at the end of this month. , ... popular styles, like A-line, mermaid, ball-gown, empire, and more. ... and other special-occasion dresses for women, and the company ...
(Date:7/23/2014)... July 23, 2014 Absolute PhysioCare and ... the launch of its custom orthotics and gait scan ... foot abnormalities in order to restore normal body balance. ... cause less fatigue and pain. In addition, Custom orthotics ... in the foot, resulting in relief and greater comfort ...
(Date:7/23/2014)... In his latest blog post at ... Per Wickstrom explains why entrepreneurs should plan for failure. ... he has never failed – and quite miserably at ... “Failure is not the opposite of success; it is ... reveals opportunities and shifts perspectives that, ultimately, are essential ...
(Date:7/23/2014)... 23, 2014 A Forever Recovery, an ... off to a great start and gives them a ... launched a new Internet Addiction section of its website ... to learn that Internet addiction is not just as ... but that it’s trapping more and more victims each ...
(Date:7/23/2014)... (PRWEB) July 23, 2014 In its latest ... programs and believes that having family close by during a ... or not the process is successful, is focusing on a ... all drug and addiction-related dialogues: opiate abuse facts. , The ... , An overview of opiates, and why ...
Breaking Medicine News(10 mins):Health Launched Its New Collection of Wedding Dresses 2Health News:Custom Orthotics at Burnaby PhysioCare Now Correct Foot Abnormalities 2Health News:Per Wickstrom’s Latest Blog Post Explains why Entrepreneurs Should Plan for Failure 2Health News:Latest A Forever Recovery Launches Internet Addiction Section on Website 2Health News:Latest Best Drug Rehabilitation Blog Post Focuses on Opiate Abuse Facts 2
... expected to be launched in New Zealand soon, targeting ... Soon, men might also be given cervical cancer vaccines ... to protect themselves against several diseases. ... of cervical cancer prevention. Most cases of cervical cancer ...
... European Union has a huge health problem of having ... ailment in the Union, that costed the bloc’s members, a ... // ,Take a look at the annual ... disease ruled, making a dent of 230 euros on an ...
... that plays a crucial role in deciding if an embryo ... gene develops into a male), could explain the high incidence ... for formation of testes is also produced by Parkinson's affected ... and University of California. ,The SRY gene was ...
... A new research at the National Institutes of Health ... by modifying the lifestyle choices, such as exercise, learning ... published in the journal Alzheimer's & Dementia. ... Affairs for the Alzheimer's Association said that specific combinations ...
... said that the number of children born out of wedlock has ... The ONS Social// Trends survey also found that in 13 other ... ,The survey said that the size of the average UK household ... "Although most children are born to married couples, this substantial rise ...
... than famous, is now going to face some competition. Private ... Canada, having garnered enough support from the several provinces in ... the Quebec government, which intended to remove the ban on ... offered to chip in and pick up costs for such ...
Cached Medicine News:Health News:Men Might Get Their Share of Cervical Cancer Vaccine As Well 2Health News:Sex Determination Gene Blamed For High Incidence Of Parkinson’s In Me 2Health News:Cognitive deterioration in the older generation can be prevented by modifying the lifestyle 2
For the direct quantitative determination of low density lipoprotein cholesterol (LDL-C) in human serum or plasma. For in vitro diagnostic use only....
Storage temperature: 15 - 30C, linearity: 0 - 20 mg/dL, expected value: male: 3.0 - 7.0 mg/dL and female: 2.2 - 6.2 mg/dL. Available with calibrator and number of tests 125....
Intended for the quantitative determination of uric acid in serum or plasma. Reaction: endpoint. Wavelength: 520 nm. Linearity: 20 mg/dL (1190 mol/L). Single vial, dry powder reagent....
... A fully automated, random ... over 50 assays available ... tumor marker, therapeutic drug, ... testing can be performed ...
Medicine Products: